PERSIA (Non-metastic breast cancer)

Figshare2020-06-28 更新2026-04-28 收录

HER2阳性乳腺癌

帕妥珠单抗临床注册研究

数据链接：

https://figshare.com/articles/dataset/PERSIA_Non-metastic_breast_cancer_/12494603 数据链接链接失效反馈

官方服务：

资源简介：

PERTUZUMAB REGISTRY IN THE NEOADJUVANT SETTING FOR HER2-POSITIVE NON-METASTATIC BREAST CANCER IN AUSTRALIA (PERSIA)

创建时间：

2020-06-28

BRD8 is a therapeutic vulnerability for overcoming resistance to dual ER/HER2 blockade therapy in HR+/HER2+ breast cancer

HER2阳性乳腺癌

单细胞RNA测序

.rda file for Seurat object of scRNA-seq data from BT474 breast cancer cell lines treated with DMSO, Neratinib, Fulvestrant, and a combination of Neratinib and Fulvestrant.

Zenodo2023-05-04 更新30

Supplementary Table S3 from Integrating Molecular Imaging and Transcriptomic Profiling in Advanced HER2-Positive Breast Cancer Receiving Trastuzumab Emtansine: An Analysis of the ZEPHIR Clinical Trial

HER2阳性乳腺癌

多组学生物标志物分析

Gene set enrichment analysis on Hallmark gene sets, on genes ranked based on the correlation between gene expression and FDG-PET uptake described by SUVmax (positive normalized enrichment score – NES

Figshare2025-01-06 更新10

Nuclear factor kappa B activation-induced anti-apoptosis renders HER2 positive cells drug resistant and accelerates tumor growth

肿瘤耐药机制

HER2阳性乳腺癌

Nuclear factor kappa B activation-induced anti-apoptosis renders HER2 positive cells drug resistant and accelerates tumor growth

ChEBI2014-02-13 更新00

RNA-seq of MMTV-Neu AXL KO tumors

HER2阳性乳腺癌

AXL受体酪氨酸激酶

AXL is activated by its ligand GAS6 and is expressed in triple-negative breast cancer cells. We report that AXL is also detected in HER2+ breast cancer specimens where its expression correlates with p

NIAID Data Ecosystem30

HER2 3-class classification performance using IHC and H&E images (BCI dataset).

HER2阳性乳腺癌

病理图像分析

HER2 3-class classification performance using IHC and H&E images (BCI dataset).

NIAID Data Ecosystem10